Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Preventing estrogen receptor action with dimer-interface peptides.

M R Yudt1, S Koide

  • 1Department of Biochemistry and Biophysics, Box 712, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.

Steroids
|April 27, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Monobody adapter for functional antibody display on nanoparticles for adaptable targeted delivery applications.

Nature communications·2022
Same author

Diffuse pollution monitoring and modelling of small urban watershed in Brazil Cerrado.

Water science and technology : a journal of the International Association on Water Pollution Research·2019
Same author

Impact of combinatorial dysfunctions of Tet2 and Ezh2 on the epigenome in the pathogenesis of myelodysplastic syndrome.

Leukemia·2016
Same author

Perception and Haptic Rendering of Friction Moments.

IEEE transactions on haptics·2016
Same author

Kidney Transplantation, Cardiovascular Risk, and Long-Term Dialysis in Japan.

Transplantation proceedings·2016
Same author

A randomized 'N-of-1' single blinded clinical trial of barbed dermal sutures vs. smooth sutures in elective plastic surgery shows differences in scar appearance two-years post-operatively.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2015
Same journal

Emerging trends for therapeutic valuation of Cyclopamine: Structural features, mechanism of action, and formulation strategies.

Steroids·2026
Same journal

The antiproliferative and antimigratory properties of the 3-biotin-B-norcholesteryl benzimidazole derivative in MCF-7 cells are mediated through G1 phase arrest and apoptosis.

Steroids·2026
Same journal

Development and validation of an LC-MS method for quantification of sex steroid hormones in skeletal muscle.

Steroids·2026
Same journal

Circulating 4β-hydroxycholesterol as a biomarker of CYP3A4 activity: beyond drug development.

Steroids·2026
Same journal

Impact of glycosylation position on flavonoid isomers' inhibition of breast cancer-associated enzyme CYP1B1.

Steroids·2026
Same journal

Synthesis NMR characterization and X-ray structure of α,β-unsaturated steroid spiroketal lactones. evaluation of cytotoxicity and anti-inflammatory activity.

Steroids·2026
See all related articles

Researchers designed an I-box peptide that disrupts human estrogen receptor-alpha (hER) dimerization, inhibiting its function. This peptide shows specificity for hER, suggesting potential for developing novel antiestrogen therapies.

Area of Science:

  • Molecular Endocrinology
  • Protein Biochemistry
  • Structural Biology

Background:

  • The human estrogen receptor-alpha (hER) is a critical ligand-activated transcription factor functioning as a homodimer.
  • Understanding hER dimerization is key to developing targeted therapies, including antiestrogens independent of ligand binding.

Purpose of the Study:

  • To elucidate the molecular mechanisms of hER dimerization.
  • To design a novel reagent targeting hER dimerization for potential antiestrogen development.

Main Methods:

  • Design and synthesis of a 16-residue 'dimer-interface' oligopeptide (I-box peptide) from the hER helical region.
  • Assessment of peptide helical propensity in aqueous solution.
  • Evaluation of the I-box peptide's effect on hER function, solubility, and aggregation in both ligand-bound and apo forms.

Related Experiment Videos

  • Site-directed mutagenesis (Ile to Pro) to assess the role of helical structure in peptide activity.
  • Testing specificity against other proteins, steroid receptors, and homologous peptides.

    • Main Results:

    • The I-box peptide exhibits high helical propensity and effectively blocks hER action by inducing aggregation and precipitation of both ligand-bound and apo-hER.
    • The observed anti-hER activity is dependent on the peptide's helical structure, as an Ile to Pro mutation abolishes this effect.
    • The I-box peptide demonstrates specificity for hER, with no significant impact on other tested proteins or steroid receptors.
    • Homologous peptides from RXRalpha and TIF2 showed no in vitro effect on hER.

    Conclusions:

    • Rationally designed peptides targeting steroid receptor quaternary structures can inhibit receptor function.
    • The I-box peptide represents a novel strategy for developing specific inhibitors of hER.
    • These findings open avenues for creating specific antiestrogen therapies by targeting receptor dimerization.